Peak6 Investments LLC Beam Therapeutics Inc. Call Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 14, 2024
BUY
$23.46 - $45.07 $251,022 - $482,249
10,700 New
10,700 $353,000
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $258,635 - $457,015
6,500 New
6,500 $310,000
Q3 2021

Nov 12, 2021
SELL
$84.37 - $133.6 $2.19 Million - $3.47 Million
-26,000 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$64.12 - $128.71 $1.67 Million - $3.35 Million
26,000 New
26,000 $3.35 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email